ArticleTherapeutic advances in endocrinology and metabolism2010

Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient.

Ghassan Jarred et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.